AU2003287797A1 - Pharmaceutical compositions, method, and use of formulation for the treatment and prevention of infections associated with helicobacter pylori in mammals and humans - Google Patents

Pharmaceutical compositions, method, and use of formulation for the treatment and prevention of infections associated with helicobacter pylori in mammals and humans

Info

Publication number
AU2003287797A1
AU2003287797A1 AU2003287797A AU2003287797A AU2003287797A1 AU 2003287797 A1 AU2003287797 A1 AU 2003287797A1 AU 2003287797 A AU2003287797 A AU 2003287797A AU 2003287797 A AU2003287797 A AU 2003287797A AU 2003287797 A1 AU2003287797 A1 AU 2003287797A1
Authority
AU
Australia
Prior art keywords
mammals
humans
formulation
prevention
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003287797A
Inventor
Jose Pedrazzoli Junior
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CMAX OTIMIZACAO DE RESULTADOS SC Ltda
Original Assignee
CMAX OTIMIZACAO DE RESULTADOS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CMAX OTIMIZACAO DE RESULTADOS filed Critical CMAX OTIMIZACAO DE RESULTADOS
Publication of AU2003287797A1 publication Critical patent/AU2003287797A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/345—Nitrofurans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
AU2003287797A 2003-04-09 2003-12-29 Pharmaceutical compositions, method, and use of formulation for the treatment and prevention of infections associated with helicobacter pylori in mammals and humans Abandoned AU2003287797A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
BRPI0300882-7 2003-04-09
BR0300882-7A BR0300882A (en) 2003-04-09 2003-04-09 Pharmaceutical compositions, method and use of formulation for treatment and prevention of infections associated with helicobacter pylori in mammals and humans
PCT/BR2003/000205 WO2004089340A1 (en) 2003-04-09 2003-12-29 Pharmaceutical compositions, method, and use of formulation for the treatment and prevention of infections associated with helicobacter pylori in mammals and humans

Publications (1)

Publication Number Publication Date
AU2003287797A1 true AU2003287797A1 (en) 2004-11-01

Family

ID=33136628

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003287797A Abandoned AU2003287797A1 (en) 2003-04-09 2003-12-29 Pharmaceutical compositions, method, and use of formulation for the treatment and prevention of infections associated with helicobacter pylori in mammals and humans

Country Status (3)

Country Link
AU (1) AU2003287797A1 (en)
BR (1) BR0300882A (en)
WO (1) WO2004089340A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR056062A1 (en) * 2006-06-05 2007-09-19 Bago Sa Labor ANTI-AGED PHARMACEUTICAL COMPOSITION IN DUST FORM, PHARMACEUTICAL PREPARATION THAT UNDERSTANDS IT AND PROCESS FOR PREPARATION
WO2008114143A1 (en) * 2007-03-22 2008-09-25 Aurobindo Pharma Limited Extended release formulations of macrolide antibiotic
WO2011079349A1 (en) * 2009-12-31 2011-07-07 Okada Medical Services Pty Ltd Okadaella gastrococcus and cancer
BR202014031413U2 (en) * 2014-12-15 2016-06-21 Ems Sa kit for joint drug administration

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6132768A (en) * 1995-07-05 2000-10-17 Byk Gulden Lomberg Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors
US5945124A (en) * 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole

Also Published As

Publication number Publication date
WO2004089340A1 (en) 2004-10-21
BR0300882A (en) 2005-05-10

Similar Documents

Publication Publication Date Title
EP1628530B8 (en) Methods and compositions for the prevention and treatment of sepsis
WO2003072035A8 (en) Compositions and methods for the treatment of immune related diseases
WO2004041170A9 (en) Compositions and methods for the treatment of immune related diseases
WO2004024097A9 (en) Compositions and methods for the treatment of immune related diseases
WO2004006858A3 (en) Compounds, compositions, and methods employing same
EP1576150A3 (en) Methods and compositions for increasing the efficacy of biologically-active ingredients
IL174301A0 (en) Pharmaceutical formulations, methods and dosing regimens for the treatment and prevention of acute coronary syndromes
AU2002254158A1 (en) Medical devices, compositions and methods for treating vulnerable plaque
AU2003231866A1 (en) Herbs and herbal combinations useful for the treatment of microbial infections
PL373302A1 (en) Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer
HK1083749A1 (en) Solid nano pharmaceutical formulation and preparation method thereof
EP1605975A4 (en) Composition and method for the treatment and prevention of enteric bacterial infections
ZA200507070B (en) Methods and compositions for the treatment and prevention of staphylococcus and other bacterial infections
AU2003290605A1 (en) Compositions and methods for the diagnosis and treatment of sepsis
IL175303A0 (en) Oral formulations for 5-ht-receptor agonists, uses and methods of treatment employing the same
AU2003270498A1 (en) Topical veterinary compositions and methods for the treatment and prevention of infection
AU2003236156A1 (en) Pharmaceutical compositions used for immune disease treatment and improvement
EP1670894B8 (en) Compositions including different types of transfer factor, methods for making the compositions, and methods of treatment using the compositions
AU2003239132A1 (en) Methods and compositions for preventing and treating microbial infections
AU2003287797A1 (en) Pharmaceutical compositions, method, and use of formulation for the treatment and prevention of infections associated with helicobacter pylori in mammals and humans
AU2003220026A1 (en) Methods and compositions for the treatment of ischemia
WO2006044548A3 (en) Clopidogrel compositions
AU2003228305A1 (en) Pharmaceutical composition with combined active agents and methods for using the same
CL2004001005A1 (en) COMPOUNDS DERIVED FROM MACROLIDS OF 15 MEMBERS, REPLACED IN POSITION 4 ", PROCEDURE FOR PREPARATION; PHARMACEUTICAL COMPOSITION THAT INCLUDES IT; AND ITS USE FOR THE TREATMENT OR PROPHYLAXIS OF SYSTEMIC MICROBIAL OR TOPIC INFECTION.
AU2003259198A1 (en) Method and composition for treating and preventing influenza infection and symptoms thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase